Updated Jul 16, 2026 · Last SEC filing 2026-06-22
CytomX Therapeutics, Inc. (CTMX) has filed 8 SEC Form 4 insider transactions in the last 90 days, with the most recent on 2026-06-22. 3 Form 8-K material event filings were reported by CTMX in the last 90 days. InsiderAlpha tracks every CTMX SEC filing — Form 4, Form 144, and 8-K — in real time, including Rule 10b5-1 plan detection.
| SEC CIK | 0001501989 |
|---|
| Form 4 filings (90d) | 8 |
|---|---|
| Form 8-K filings (90d) | 3 |
| Latest Form 4 filing | 2026-06-22 |
| Date | Insider | Role | Transaction | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Ogden Christopher | Chief Financial Officer | S — Open-market sale | 1.6K | $3.05 | $5K | SEC | |
| Ogden Christopher | Chief Financial Officer | S — Open-market sale | 19.3K | $6.42 | $124K | SEC | |
| Chu Yu-Waye | Chief Medical Officer | S — Open-market sale | 21.3K | $6.42 | $137K | SEC | |
| McCarthy Sean A. | CEO | S — Open-market sale | 119.0K | $6.42 | $764K | SEC | |
| BELVIN MARCIA | SVP, Chief Scientific Officer | S — Open-market sale | 31.5K | $6.42 | $202K | SEC | |
| Lester Rachael | Chief Business Officer | A — Grant or award | 20.0K | $0.00 | — | SEC | |
| Chu Yu-Waye | Chief Medical Officer | A — Grant or award | 75.0K | $0.00 | — | SEC | |
| BELVIN MARCIA | SVP, Chief Scientific Officer | A — Grant or award | 60.0K | $0.00 | — | SEC | |
| Ogden Christopher | Chief Financial Officer | A — Grant or award | 90.0K | $0.00 | — | SEC | |
| McCarthy Sean A. | CEO | A — Grant or award | 210.0K | $0.00 | — | SEC |
All transactions sourced from SEC EDGAR Form 4 filings for CytomX Therapeutics, Inc. (CTMX). Updated in real time as new filings are submitted to the SEC.
| Insider | Form 4 filings | Total transaction value |
|---|---|---|
| Ogden Christopher | 1 | $5K |
| Meyers James R | 1 | — |
| Mohindru Mani | 1 | — |
| Jones Elaine V | 1 | — |
| Gilbert Halley E | 1 | — |
SEC Form 4 transactions are reported with a one-letter code indicating the type of transaction. Common codes you'll see in CTMX insider filings:
| P | Open-market purchase by the insider |
|---|---|
| S | Open-market sale by the insider |
| A | Grant, award, or other acquisition from the issuer |
| M | Exercise or conversion of derivative security (e.g. options) |
| F | Payment of exercise price or tax liability via share withholding |
| G | Bona-fide gift of securities |
| D | Disposition to the issuer (e.g. share buyback participation) |
| J | Other acquisition or disposition |
| X | Exercise of in-the-money or at-the-money derivative security |
| C | Conversion of derivative security |
| V | Transaction voluntarily reported earlier than required |
Open the live CTMX dashboard on InsiderAlpha for real-time alerts, charting, and full historical filing search.